You are assuming wheezo's usefulness for the consumer will be such a massive difference in the US compared to Australia's cost of only a coffee per month and a big percentage of consumer who bought the $100 device aren't even re-subscribing for that very small monthly expense to use something apparently thought as very useful. RSH planning to do studies on the usefulness of wheezo told you something didn't it????
RSH's MC is heading toward the MC of the company it tried to do that strange unsuccessful T/O but that company has nearly $8M in funding left. Someone selling on more volumes than previously to 1c below the 4.5c CR is saying something which isn't looking good......
RSH Price at posting:
3.6¢ Sentiment: Hold Disclosure: Not Held
